Article Sidebar

Submitted
January 24, 2025
Accepted
January 24, 2025
Published
January 24, 2025
Download
pdf
Statistic
Read Counter : 384 Download : 322

Main Article Content

Abstract

Ischemia/reperfusion injury is a complicated phenomenon leading to cellular damage via the
biphasic process. Ischemia causes injury by reducing or entirely eliminating the energy supply required
for homeostasis. Reperfusion exacerbates cellular damage through several proposed mechanisms,
including inflammatory responses and the production of free radicals and oxygen. A total of 24 adult male
rats were randomly divided into four groups(n=6). Sham group: Rats were anesthetized and had a
surgery without ischemia-reperfusion induction. I/R control group: Rats underwent a same anesthetic
procedure, followed by 40 min bilateral renal ischemia, then 2 hr. of reperfusion. DMSO group: Rats
were received DMSO (as a solvent for alogliptin) ip injection at 24hr and 30 min. before surgery (an
identical surgical technique as the control group). Alogliptin treated group: Rats were received
alogliptin ip injection 10 mg/kg at 24h and 30 min. before surgery (an identical surgical technique as the
control group). All rats had their blood samples and renal tissues collected the conclusion of the
reperfusion phase. In blood samples, serum urea and creatinine were measured by the standard laboratory
protocols, and by using ELISA method, KIM-1 measurement was taken in kidney tissues. Furthermore,
kidney histopathological investigation was conducted by assessing the extent of degeneration, tubular
dilation, interstitial lymphocyte infiltration, and loss of brush borders. It was concluded that kidney
damage resulted from elevated urea, creatinine, and KIM-1 levels noted in blood samples and kidney
tissues of rats in both control and DMSO groups in contrast with sham group. In comparison to the
control and DMSO groups, rats in the treatment group showed decreasing levels of urea, creatinine, and
KIM-1, Furthermore, the treated group with alogliptin also had decreased histopathological damage
scores. these results suggest that alogliptin can prevent kidney damage as mainly evidenced by the
decreased histopathological damage region, enhanced renal functions. Alogliptin's characteristics may
facilitate its application in the management of acute kidney injury (AKI).

Keywords

Alogliptin ischemia/reperfusion urea creatinine Kim-1

Article Details

License

Copyright (c) 2025 University of Thi-Qar Journal Of Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

References

  1. KALOGERIS, T., BAINES, C. P., KRENZ, M. & KORTHUIS, R. J. 2012. Cell biology of
  2. ischemia/reperfusion injury. Int Rev Cell Mol Biol, 298, 229-317.
  3. OLIVEIRA, T. H. C., MARQUES, P. E., PROOST, P. & TEIXEIRA, M. M. M. 2018.
  4. Neutrophils: a cornerstone of liver ischemia and reperfusion injury. Lab Invest, 98, 51-62.
  5. CHIANG, C. K., LOH, J. Z., YANG, T. H., HUANG, K. T., WU, C. T., GUAN, S. S., LIU, S.
  6. H. & HUNG, K. Y. 2020. Prevention of acute kidney injury by low intensity pulsed
  7. ultrasound via anti-inflammation and anti-apoptosis. Sci Rep, 10, 14317.
  8. GOWDA, S., DESAI, P. B., KULKARNI, S. S., HULL, V. V., MATH, A. A. & VERNEKAR,
  9. S. N. J. N. A. J. O. M. S. 2010. Markers of renal function tests. 2, 170.
  10. ISMAIL, O. Z., ZHANG, X., WEI, J., HAIG, A., DENKER, B. M., SURI, R. S., SENER, A. &
  11. GUNARATNAM, L. 2015. Kidney injury molecule-1 protects against Galpha12
  12. activation and tissue damage in renal ischemia-reperfusion injury. Am J Pathol, 185,
  13. -15.
  14. WANG, M., WENG, X., CHEN, H., CHEN, Z. & LIU, X. J. A. C. B. 2020. Resveratrol inhibits
  15. TNF-α-induced inflammation to protect against renal ischemia/reperfusion injury in
  16. diabetic rats. Acta Cirurgica Brasileira, 35, e202000506.
  17. COVINGTON, P., CHRISTOPHER, R., DAVENPORT, M., FLECK, P., MEKKI, Q. A.,
  18. WANN, E. R. & KARIM, A. J. C. T. 2008. Pharmacokinetic, pharmacodynamic, and
  19. tolerability profiles of the dipeptidyl peptidase-4 inhibitor alogliptin: a randomized,
  20. double-blind, placebo-controlled, multiple-dose study in adult patients with type 2
  21. diabetes. Clinical therapeutics, 30, 499-512.
  22. TORRES-GONZÁLEZ, L.,CIENFUEGOS-PECINA, E., PERALES-QUINTANA, M. M.,
  23. ALARCON-GALVAN, G., MUÑOZ-ESPINOSA, L. E., PÉREZ-RODRÍGUEZ, E.,
  24. CORDERO-PÉREZ, P. J. O. M. & LONGEVITY, C. 2018. Nephroprotective effect of
  25. Sonchus oleraceus extract against kidney injury induced by ischemia‐reperfusion in
  26. wistar rats. Oxidative medicine and cellular longevity, 2018, 9572803.
  27. HERRERA-LUNA, Y., LOZANO, M., PASTEN, C., MULTHOFF, G. & IRARRAZABAL, C.
  28. E. 2022. The Ischemia and Reperfusion Injury Involves the Toll-Like Receptor-4
  29. Participation Mainly in the Kidney Cortex. Cell Physiol Biochem, 56, 613-628.
  30. Najah R. Hadi, Fadhil AL-amran, Thu-Alfeqar R. Tweij, Mohammed E. Mansur. CDDO Me
  31. Provides Kidney Protective Impacts Against Ischemia/Reperfusion Injury via Inhibition
  32. Thi-Qar Medical Journal (TQMJ): Vol. (28), No. (2), 2024
  33. Web Site: https://jmed.utq.edu
  34. Email: utjmed@utq.edu.iq
  35. ISSN (Print):1992-9218 ISSN (Online): 3006-4791
  36. of Oxidative Stress and Inflammation by Targeting Nrf2 and NF-kB Signaling Pathways.
  37. Systematic Reviews in Pharmacy. 2020;11(1):108-118.
  38. SALVATORE, T., PAFUNDI, P. C., MARFELLA, R., SARDU, C., RINALDI, L., MONACO,
  39. L., RICOZZI, C., IMBRIANI, S., NEVOLA, R., ADINOLFI, L. E. & SASSO, F. C.
  40. Metformin lactic acidosis: Should we still be afraid? Diabetes Research and
  41. Clinical Practice, 157.
  42. Wei, Q., Bhatt, K., He, H.-Z., Mi, Q.-S., Haase, V. H., & Dong, Z. (2010). Targeted deletion of
  43. Dicer
  44. from proximal tubules protects against renal ischemia-reperfusion injury. Journal
  45. of the American Society of Nephrology, 21(5), 756-761.
  46. LASORSA, F., RUTIGLIANO, M., MILELLA, M., D’AMATI, A., CROCETTO, F.,
  47. PANDOLFO, S. D., BARONE, B., FERRO, M., SPILOTROS, M., BATTAGLIA, M.,
  48. DITONNO, P. & LUCARELLI, G. 2024. Ischemia–Reperfusion Injury in Kidney
  49. Transplantation: Mechanisms and Potential Therapeutic Targets. International Journal of
  50. Molecular Sciences, 25, 4332.
  51. HAN, B. H., LEE, H. K., JANG, S. H., TAI, A. L., JANG, Y. J., YOON, J. J., KIM, H. Y., LEE,
  52. H. S., LEE, Y. J. & KANG, D. G. 2021. Effect of Geumgwe-Sinkihwan on Renal
  53. Dysfunction in Ischemia/Reperfusion-Induced Acute Renal Failure Mice. Nutrients, 13.
  54. SAKR, S. & KAMEL, M. 2023. Effect of Alogliptin and L-carnitine on Nephrotoxicity
  55. Inducedby Gentamicin in Rats. Zagazig Veterinary Journal, 51, 45-58.
  56. BOTROS, S. R., MATOUK, A. I., AMIN, A. & HEEBA, G. H. 2024. Comparative effects of
  57. incretin-based therapy on doxorubicin-induced nephrotoxicity in rats: the role of
  58. SIRT1/Nrf2/NF-kappaB/TNF-alpha signaling pathways. Front Pharmacol, 15, 1353029.

Similar Articles

You may also start an advanced similarity search for this article.